Aspira Pathlab & Diagnostics Ltd
BSE:540788
Aspira Pathlab & Diagnostics Ltd
BSE:540788
Price:
54.75
INR
-5.6%
Market Cap:
₹563.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aspira Pathlab & Diagnostics Ltd
BSE:540788
|
IN |
|
C
|
Concord New Energy Group Ltd
HKEX:182
|
HK |
|
Mission Group PLC
LSE:TMG
|
UK |
|
T
|
Toyota Motor Corp
OTC:TOYOF
|
JP |
|
TSS Inc
OTC:TSSI
|
US |
Balance Sheet
Balance Sheet Decomposition
Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab & Diagnostics Ltd
Balance Sheet Decomposition is not available for
Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab & Diagnostics Ltd
Balance Sheet
Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab & Diagnostics Ltd
Currency: INR
| Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
2
|
0
|
31
|
53
|
28
|
2
|
1
|
11
|
12
|
16
|
23
|
14
|
21
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
3
|
18
|
6
|
4
|
|
| Cash Equivalents |
2
|
0
|
31
|
53
|
28
|
2
|
1
|
1
|
12
|
14
|
6
|
8
|
18
|
|
| Total Receivables |
5
|
6
|
7
|
2
|
6
|
10
|
17
|
17
|
23
|
50
|
29
|
24
|
26
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
1
|
4
|
8
|
6
|
17
|
45
|
23
|
22
|
24
|
|
| Other Receivables |
0
|
0
|
6
|
1
|
5
|
6
|
9
|
11
|
6
|
5
|
6
|
2
|
2
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
4
|
3
|
3
|
4
|
4
|
4
|
4
|
5
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
5
|
2
|
2
|
2
|
1
|
1
|
2
|
1
|
2
|
|
| Total Current Assets |
6
|
6
|
38
|
57
|
40
|
18
|
23
|
33
|
39
|
71
|
59
|
44
|
54
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
69
|
69
|
62
|
60
|
50
|
68
|
53
|
41
|
39
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
9
|
9
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
6
|
6
|
4
|
1
|
1
|
3
|
31
|
32
|
33
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
33
|
23
|
0
|
11
|
4
|
3
|
22
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
23
|
23
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
9
|
9
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
|
| Total Assets |
6
N/A
|
6
+3%
|
38
+506%
|
63
+65%
|
149
+136%
|
125
-16%
|
148
+18%
|
143
-3%
|
118
-18%
|
181
+54%
|
173
-4%
|
147
-15%
|
175
+19%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
3
|
2
|
3
|
4
|
7
|
6
|
3
|
7
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
26
|
36
|
1
|
20
|
23
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
5
|
8
|
8
|
5
|
8
|
6
|
7
|
7
|
8
|
|
| Other Current Liabilities |
0
|
0
|
2
|
0
|
13
|
6
|
11
|
19
|
5
|
5
|
6
|
6
|
8
|
|
| Total Current Liabilities |
0
|
0
|
2
|
27
|
58
|
16
|
42
|
51
|
20
|
18
|
16
|
21
|
24
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
32
|
105
|
48
|
52
|
13
|
33
|
26
|
21
|
24
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
6
|
2
|
2
|
3
|
4
|
4
|
6
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
2
N/A
|
27
+1 193%
|
89
+236%
|
122
+36%
|
96
-21%
|
105
+10%
|
35
-67%
|
53
+54%
|
46
-14%
|
46
-1%
|
53
+16%
|
|
| Equity | ||||||||||||||
| Common Stock |
4
|
4
|
22
|
23
|
52
|
52
|
82
|
93
|
103
|
103
|
103
|
103
|
103
|
|
| Retained Earnings |
2
|
2
|
14
|
14
|
7
|
49
|
30
|
55
|
20
|
25
|
25
|
1
|
19
|
|
| Total Equity |
6
N/A
|
6
+3%
|
36
+473%
|
36
+1%
|
59
+63%
|
3
-94%
|
52
+1 451%
|
38
-27%
|
83
+119%
|
128
+54%
|
128
0%
|
101
-20%
|
122
+20%
|
|
| Total Liabilities & Equity |
6
N/A
|
6
+3%
|
38
+506%
|
63
+65%
|
149
+136%
|
125
-16%
|
148
+18%
|
143
-3%
|
118
-18%
|
181
+54%
|
173
-4%
|
147
-15%
|
175
+19%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
5
|
5
|
5
|
2
|
5
|
5
|
8
|
9
|
10
|
10
|
10
|
10
|
10
|
|
Switch to:
Switch to:
See Also
Discover More
